A contentious debate among diabetes researchers has surrounded the regeneration of pancreatic insulin-producing cells: not if these cells regenerate, but rather how. The long-held view that the islets of Langerhans can be replenished from pancreatic stem cells (progenitors) was replaced over the last decade by the notion that islets self-duplicate from existing cells. Now, in […]Continue Reading ...
The Pancreatic Cancer Collective, the strategic partnership of the Lustgarten Foundation and Stand Up To Cancer (SU2C), has awarded a total of $7 million in first-round “New Therapies Challenge” grants to seven teams of top cancer researchers to explore new pancreatic cancer treatments, the American Association for Cancer Research, the Scientific Partner of SU2C, announced […]Continue Reading ...
Nov 15 2018 Pancreatic cancer death rates in the European Union (EU) have increased by 5% between 1990 and 2016, a report launched today reveals. This is the highest increase in any of the EU’s top five cancer killers which, as well as pancreatic cancer, includes lung, colorectal, breast and prostate cancer. Number of Pancreatic […]Continue Reading ...
You’re experiencing jaundice, abdominal pain or constipation. And by then, you may be too late. Pancreatic cancer symptoms often arrive after the cancer has already spread, making the disease one of the leading causes of cancer deaths in the U.S. However, a team of researchers believes that targeting how blood clots form and are naturally […]Continue Reading ...
A new approach to treating pancreatic cancer using ‘educated killer cells’ has shown promise, according to early research by Queen Mary University of London. The new cell-based immunotherapy, which has not yet been tested in humans with pancreatic cancer, led to mice being completely cancer-free, including cancer cells that had already spread to the liver […]Continue Reading ...
LYON, France and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) — Erytech Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced that the first three patients have been enrolled in its pivotal Phase 3 clinical trial, named ‘TRYbeCA1’, evaluating its […]Continue Reading ...
A treatment for highly aggressive and commonly fatal pancreatic cancer is being developed, reports a University of Houston researcher who has designed a new medicine that can inhibit two of the major pathways of the deadly disease. Ruiwen Zhang, M.D., Ph.D. and Robert L. Boblitt Endowed Professor in Drug Discovery, has published his findings, along […]Continue Reading ...
August 3, 2018 A high-fat diet may promote the growth of pancreatic cancer independent of obesity because of the interaction between dietary fat and cholecystokinin (CCK), a digestive hormone. In addition, blocking CCK may help prevent the spread of pancreatic tumors to other areas of the body (metastases). The new findings are published ahead of […]Continue Reading ...
Research on a new way of deploying the immune system against pancreatic cancer, an exceptionally lethal cancer that has so far resisted new immunotherapies, will receive $1 million in initial funding from Stand Up to Cancer. The project led by researchers from The University of Texas MD Anderson Cancer Center and Baylor College of Medicine […]Continue Reading ...
New research has linked adolescent obesity with up to a four-fold increased risk of pancreatic cancer later in life. The study’s results also suggest that overweight and even higher weight within the “normal” weight range in men may increase pancreatic cancer risk in a graded manner. The findings are published early online in CANCER, a […]Continue Reading ...
Pancreatic cancer is one of the most difficult cancers to treat and is a leading cause of cancer-related deaths. Now, Sidney Kimmel Cancer Center – Jefferson Health and Lankenau Institute for Medical Research scientists find that a gene involved in the immune system called IDO2 plays a significant role in pancreatic ductal adenocarcinoma (PDAC), the […]Continue Reading ...
In a new study from Lawson Health Research Institute and Western University’s Schulich School of Medicine & Dentistry, researchers have found that mutation of a gene called ATRX may lead to increased risk of developing pancreatitis and pancreatic cancer in females. The study marks the first time a sex-specific genetic risk factor for pancreatic cancer […]Continue Reading ...
Pancreatic cancer is currently very difficult to detect while it is still resectable. A new blood test developed by researchers at Lund University in Sweden, Herlev Hospital, Knight Cancer Center and Immunovia AB, can detect pancreatic cancer in the very earliest stages of the disease. The results have been published in the Journal of Clinical […]Continue Reading ...
Pancreatic cancer is the fourth most common cause of cancer related deaths in the United States with a five-year survival rate of less than 10 percent. Although it is defined by a small number of genetic alterations, efforts to pharmacologically target specific pathways have been unsuccessful. Researchers have found that “squamous-like” pancreatic cancer, a subtype […]Continue Reading ...
July 18, 2018 Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS (British Journal of Surgery) study indicates that breath analyses may help detect pancreatic cancer earlier, when curative treatments may be possible. For the study, investigators examined volatile organic compounds in breath samples […]Continue Reading ...
- Obesity to Blame for Almost 1 in 25 Cancers Worldwide
- How the brain tells you to scratch that itch
- New findings could help develop new immunotherapies against cancer
- World’s largest AI-powered medical research network launched by OWKIN
- Young people suffering chronic pain battle isolation and stigma as they struggle to forge their identities
- Lifespan extension at low temperatures depends on individual’s genes, study shows
- New ingestible capsule can be controlled using Bluetooth wireless technology
- Researchers uncover microRNAs involved in the control of social behavior
- Research offers hope for patients with serious bone marrow cancer
- Link between poverty and obesity is only about 30 years old, study shows
- Mass spectrometry throws light on old case of intentional heavy metal poisoning
- BeyondSpring Announces Phase 3 Study 105 of its Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Meets Primary Endpoint at Interim Analysis
- Study finds that in treating obesity, one size does not fit all
- Tenacity and flexibility help maintain psychological well-being, mobility in older people
- Study reveals role of brain mechanism in memory recall
- High levels of oxygen encourage the brain to remain in deep, restorative sleep
- Experimental HIV vaccine strategy works in non-human primates, research shows
- Genetically modified pigs could limit replication of classical swine fever virus, study shows
- FDA Approves Herzuma (trastuzumab-pkrb), a Biosimilar to Herceptin
- Cost and weight-loss potential matter most to bariatric surgery patients